Chronic high-dose dimenhydrinate use contributing to early multifactorial cognitive impairment.
| Autor: | Fabiano N; Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada., Dholakia S; Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada.; Department of Mental Health, Ottawa Hospital, Ottawa, Ontario, Canada., Walker LAS; Neuroscience, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Smith AL; Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada andrewlsmith@toh.ca.; Department of Mental Health, Ottawa Hospital, Ottawa, Ontario, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMJ case reports [BMJ Case Rep] 2024 Mar 07; Vol. 17 (3). Date of Electronic Publication: 2024 Mar 07. |
| DOI: | 10.1136/bcr-2023-258493 |
| Abstrakt: | Dimenhydrinate is an over-the-counter antihistaminergic medication with anticholinergic properties used to treat nausea or motion sickness worldwide. There is a well-established correlation between the use of anticholinergic medications and dementia, however, it is unclear if a causal role exists. We report a case of minor neurocognitive disorder in a woman in her 40s with several years of high-dose daily dimenhydrinate abuse who subsequently developed significant delusional beliefs. Her clinical presentation was confounded by numerous other factors that could have impacted her cognition, such as a longstanding presumed learning disability, ankylosing spondylitis with adalimumab treatment, extensive cannabis use or potential development of a primary psychotic disorder. Her workup was within normal limits, and she has not responded to first-line antipsychotic medications to date. This case report adds to the growing evidence supporting concerns about potentially irreversible cognitive deficits in chronic misuse of anticholinergic agents, an association previously observed only in the elderly population. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|